
Jazz Pharmaceuticals (JAZZ) Market Capitalization Overview
Market Cap: $11.42B as of Mar 11, 2026
$11.42B
$1.36B (13.42%)past month
As of Mar 11, 2026, Jazz Pharmaceuticals (JAZZ) has a market capitalization of $11.42B. Over the past 30 days, its market cap has increased by 15.34%, while in the last 12 months, it has increased by 10.5%.
Market capitalization represents the total value of Jazz Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Jazz Pharmaceuticals (JAZZ) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Jazz Pharmaceuticals (JAZZ) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Jazz Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Jazz Pharmaceuticals (JAZZ) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Jazz Pharmaceuticals (JAZZ) helps investors assess the company's size and compare it with competitors for better investment decisions.
Jazz Pharmaceuticals (JAZZ) Market Cap & Key Trends
See Jazz Pharmaceuticals’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Jazz Pharmaceuticals (JAZZ)
Order type
Buy in
Order amount
Est. shares
0 shares
Jazz Pharmaceuticals (JAZZ) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $10.46B | +24.60% |
| Nov 3, 2025 | $8.40B | +1.08% |
| Oct 1, 2025 | $8.31B | +5.58% |
| Sep 2, 2025 | $7.87B | +12.51% |
| Aug 1, 2025 | $6.99B | +5.56% |
| Jul 1, 2025 | $6.63B | -0.81% |
| Jun 2, 2025 | $6.68B | -7.56% |
| May 1, 2025 | $7.23B | -4.86% |
| Apr 1, 2025 | $7.60B | -10.86% |
| Mar 3, 2025 | $8.52B | +15.49% |
| Feb 3, 2025 | $7.38B | -1.45% |
| Jan 2, 2025 | $7.49B | +1.79% |
Jazz Pharmaceuticals (JAZZ) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $11.42B | +10.50% |
| 2025 | $10.34B | +38.75% |
| 2024 | $7.45B | -3.86% |
| 2023 | $7.75B | -22.80% |
| 2022 | $10.04B | +28.09% |
| 2021 | $7.84B | — |
FAQs About Jazz Pharmaceuticals (JAZZ) Market Cap
As of Mar 11, 2026, the market capitalization of Jazz Pharmaceuticals (JAZZ) is $11.42B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Jazz Pharmaceuticals’s market capitalization has increased by 13.42%, changing from $10.07B to $11.42B as of Mar 11, 2026.
In the last 3 months, Jazz Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Jazz Pharmaceuticals’s market capitalization increased from $7.45B in January to $10.34B in December, reflecting a 38.75% change.
In the past five years, Jazz Pharmaceuticals (JAZZ) has had a compound annual growth rate (CAGR) of 5.70% in market capitalization. This means its market cap has grown at an average rate of 5.70% per year.